Gene Query: PPP1R3B

Dataset Description Geneva Score
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 150.95
RNA-sequencing of human liver tissue 80.33
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 74.63
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 74.63
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 69.71
PGE2 mediated gene expression changes in human cervical stromal cells 66.82
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 65.61
Statins modulate endothelial transcriptional profile by inhibiting EZH2 51.3
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival 49.71
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival [RNA-Seq] 49.71
Transcriptomic of MKD (MUC1 kidney disease) patient compares to normal derived kidney epithelial cells 43.17
DIGIT regulates endoderm differentiation of human embryonic stem cells 38.94
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 38.82
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 38.75
RNA-Seq from early time points in the kidney differentiation protocol 37.89
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 37.73
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 36.82
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 33.98
Role of CD133 molecule in WNT response and renal repair 33.41
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 33.01
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 32.55
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 32.55
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 31.91
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 31.06
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 30.56
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 29.84
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 29.56
Heterozygous and homozygous knock-in of PIK3CA-H1047R into human iPSCs 29.02
AR-independent prostate cancer is sustained through FGF signaling 28.23
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 27.33
Human embryonic stem cells in E8 and AKIT culture medium 27.33
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 26.11
Molecular mechanism underlying increased ischemic damage in the ALDH2*2 genetic polymorphism using a human iPSC model system 26.03
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 26.01
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 25.51
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 24.95
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 24.49
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 24.37
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 24.3
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 24.05
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 24.05
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 23.91
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 23.08
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 23.08
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 22.92
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 22.76
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 22.76
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 21.88
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 21.46
Examining serotonergic neuron differentiation from human iPSCs 21.38
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 21.15
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 20.91
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 20.91
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 20.6
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 20.55
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 20.24
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 19.88
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 19.77
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 19.45
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 19.04
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 18.84
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 18.45
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 18.43
Region-specific Innate Antiviral Responses of the Human Epididymis 18.35
Ectoderm specification of H1 human embryonic stem cells 18.33
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 17.74
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 17.67
Gene expression profiling via RNA sequencing of patient brain tumors cultured in 3D bioengineered cultures 17.66
STX4 Over-Expression in Human islets 17.64
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 17.51
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma (RNA-seq) 17.37
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma 17.37
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 17.32
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 17.21
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 17.04
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 16.97
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 16.71
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 16.71
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 16.69
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 16.6
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 16.55
A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets [bulk vs buds] 16.51
Paxillin regulates genomic networks in prostate cancer [LNCaP] 16.45
Developmental stage specific chromosome architecture in human erythroid cells 16.41
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 16.41
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 16.21
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 16.21
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 16.19
Investigation about fibroblasts of different origins in culture 16.19
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 15.74
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 15.67
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 15.66
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 15.39
Targeted differentiation of regional ventral neuroprogenitors and related neuronal subtypes from human pluripotent stem cells 15.35
BI Human Reference Epigenome Mapping Project 15.35
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 15.29
Hijacking of stress response machinery by oncogenes in acute leukaemia 15.29
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 15.18
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 15.1
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 14.83
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 14.81
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 14.81
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 14.8
Transcriptome analysis of U87 cells upon LINC00152 knockdown 14.79
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 14.57
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 14.51
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 14.23
Effect of MDK expressing Melanoma cells conditioned media in Human LEC 14.14
Dysregulated immune system networks in war veterans with PTSD 14.08
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 14.04
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 14.01
Transcriptional Signatures of Hypoxic and Inflammatory Renal Epithelial Injury 13.99
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 13.91
RNA-seq analysis of control and Myc-induced U2OS cells 13.64
Transcription profile analysis of wild type and Irf9-/- human monocytic THP1 cells in response to type I interferons 13.59
Irf9 function in immunity in mouse 13.59
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 13.54
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 13.54
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 13.39
Transcriptome wide analysis of classically and alternatively activated macrophages 13.33
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 13.3
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 13.25
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 13.16
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 13.09
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 13.04
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 13.03
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 13.03
Hypoxic transcriptome of SQ20B human head and neck cancer cells 12.98
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq 12.98
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 12.93
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 12.93
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 12.91
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 12.9
Epigenomic landscape during organ formation in human early embryos 12.77
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 12.59
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 12.59
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 12.58
Differential gene expressions in the heart of hypertrophic cardiomyopathy patients 12.5
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 12.47
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 12.42
Effect of CHKA knockdown on C4-2 cell transcriptome 12.35
Single-nucleotide-resolution mapping of HBV promoters using CAGE 11.81
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 11.57
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 11.38
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 11.36
RNA-seq of stable and unstable section of human atherosclerotic plaques 11.34
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 11.29
Generation of targeted homozygosity in the genome of human induced pluripotent stem cells 11.29
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 11.28
Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells 11.28
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 11.27
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 11.23
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 11.16
Non-coding regions are the main source of tumor-specific antigens 11.13
Non-coding regions are the main source of tumor-specific antigens [human] 11.13
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] 11.09
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 11.09
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 11.08
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 11.05
Verification and rectification of cell type-specific splicing of a Seckel syndrome-associated ATR mutation using iPS cell model 11.05
Gene expression profiles of brain endothelial cells during embryonic development at bulk and single-cell levels 10.96
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 10.96
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 10.93
Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets 10.83
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 10.73
Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia 10.72
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 10.7
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 10.61
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 10.61
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 10.52
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 10.46
Molecular Mechanisms of Endothelial Hyperpermeability 10.45
hESC neural differentiation 10.44
RNA-seq analysis of gene expression patterns during hESC neural differentiation 10.44
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 10.37
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 10.35
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 10.35
Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer 10.33
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 10.28
Comprehensive RNA sequencing of healthy human endometrium at two time points of the menstrual cycle 10.23
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 10.2
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 10.17
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 10.07
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 10.06
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 10.05
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 10.05
Selective suppression of endothelial cytokine production by progesterone receptor 9.99
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 9.99
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 9.91
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 9.89
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 9.88
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 9.87
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 9.81
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 9.73
Transcriptomic profiling of human peripheral blood-derived mast cells 9.58
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 9.58
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 9.58
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 9.58
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 9.54
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 9.44
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 9.44
Transcriptome of human white and brown adipose tissue biopsies 9.43
Transcriptome analysis of H9 hESC derived cerebral organoids 9.4
RNA-seq of RKO cells with cTAZ KO or putback 9.39
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 9.36
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 9.36
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 9.31
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 9.31
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 9.3
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 9.27
LncRNA expression profiling of ischemic stroke patients 9.26
RNA-seq analysis of differentiating human erythroblasts 9.22
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 9.18
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 9.17
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 9.17
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 9.15
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 9.11
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 9.1
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 9.08
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 8.96
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 8.89
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 8.84
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 8.73
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 8.7
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 8.62
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 8.51
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 8.51
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 8.51
Interphase condensins regulate ligand-depedent enhancer activation 8.49
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 8.49
RNA-Seq in neutrophils from Antiphospholipid Syndrome 8.45
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 8.41
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 8.36
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 8.33
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 8.3
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 8.3
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 8.27
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 8.22
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 8.19
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 8.19
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 8.13
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 8.11
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 8.06
Exploring the RNA landscape of endothelial exosomes 8.01
Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation 7.98
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 7.91
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 7.89
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 7.84
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 7.8
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 7.78
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 7.77
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 7.74
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 7.74
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 7.71
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 7.7
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 7.7
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 7.69
A High-Throughput Screen Identifies DYRK inhibitor ID-8 that Stimulates Human Kidney Tubular Proliferation 7.66
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 7.66
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 7.66
De novo reconstruction of human adipose reveals conserved lncRNAs as regulators of brown adipogenesis 7.5
High-throughput sequencing of pluripotent cells 7.5
The effect of Foxc1 deficiency on undifferentiated and differentiated human primary keratinocytes 7.49
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 7.46
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 7.46
Zone dependent distinctive gene expression profile of the normal human liver tissue 7.44
7.37
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 7.28
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 7.28
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 7.26
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 7.2
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 7.16
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 7.16
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 7.14
7.12
The transcriptome and chromatin accessbility landscape of mammalian germline 7.1
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier 7.03
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier [human] 7.03
Transcriptome variation among human embryonic stem cell lines impacts on their differentiation 7.02
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 6.99
Derivation and differentiation of haploid human embryonic stem cells [RNA-Seq 1] 6.83
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 6.77
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 6.76
Next Generation Sequencing Analysis of human embryonic stem cells derived MESP1-mTomato reporter cells 6.7
Transcriptional differences between skin from patients with atopic dermatitis and control skin obtained from the healthy margins of Mohs surgery patients 6.69
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 6.68
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 6.53
ARID1A regulates condensin II distribution and chromosomal partition 6.49
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 6.49
Small-molecule targeting of brachyury transcription factor addiction in chordoma 6.4
Derivation and differentiation of haploid human embryonic stem cells 6.29
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 6.28
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 6.28
Lineage specific differentiation is influenced by state of human pluripotency 6.28
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 6.25
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 6.25
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] 6.2
Tpl-2 and MEK small molecule inhibitors 6.17
Tpl-2 small molecule project 6.17
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 6.06
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 6.06
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 6.04
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 6.04
RNA-seq of naive and primed ES cells 6.03
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 6.03
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 5.97
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 5.91
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 5.89
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 5.88
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 5.78
RNA-seq identifies novel lncRNAs involved in vascular smooth muscle cell proliferation 5.78
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 5.76
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 5.72
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 5.72
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 5.61
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 5.56
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 5.56
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 5.54
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 5.54
RNAseq of IL-36 stimulated primary human keratinocytes 5.52
Endometrial transcriptome and PGR cistrome in cycling fertile women 5.5
Endometrial transcriptome and PGR cistrome in cycling fertile women [RNA-seq] 5.5
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment 5.47
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 5.46
Molecular Criteria for Defining the Naive Human Pluripotent State 5.42
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 5.41
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 5.38
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 5.35
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 5.33
Capturing the Interactome of Newly Transcribed RNA (RICK) 5.32
Capturing the Interactome of Newly Transcribed RNA 5.32
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 5.32
tRNA modification landscape selectively controls mitochondrial translation efficiency in MERRF 5.31
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 5.31
PANCR, the PITX2 adjacent noncoding RNA, is specifically expressed in human left atria and regulates PITX2c expression 5.3
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 5.3
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 5.27
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 5.24
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 5.24
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 5.24
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 5.16
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 5.15
Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition 5.12
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 5.07
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 5.07
mRNA expression data from ESCs derived by polar body transfer reconstructed embryos (PBTESCs) 5.07
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 5.06
Dilated cardiomyopathy vs Myocarditis 5.05
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 5.0
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 5.0
Gene expression changes due to PARP knockdown in human cells 4.97
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 4.95
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 4.88
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 4.79
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 4.78
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 4.78
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 4.68
Identification of expressed and conserved human non-coding RNAs 4.66
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 4.66
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 4.65
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 4.64
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 4.63
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 4.49
STRIPAK directs PP2A activity to promote oncogenic transformation 4.49
AMPK signaling for naïve pluripotency 4.49
AMPK signaling for naïve pluripotency [Hs] 4.49
RNA-Seq profiling of iPSC-derived ventricular and atrial cardiomyocytes 4.41
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 4.41
The effect of insulin on mRNA transcription of human pluripotent stem cells 4.4
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 4.4
Identification of a LIF-responsive replication-competent human β cell 4.27
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells 4.19
Leucegene: AML sequencing (part 6) 4.17
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 4.13
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 4.13
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 4.13
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 4.05
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 3.99
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 3.94
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 3.83
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 3.77
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 3.75
Chemical Enhancement of Direct Cardiac Reprogramming In Vitro and In Vivo 3.67
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 3.62
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 3.62
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 3.58
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 3.52
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 3.46
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 3.44
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 3.44
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 3.43
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism: Liver RNA profiles of lean non-diabetic, obese non-diabetic as well as obese diabetic humans. 3.41
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism. 3.41
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 3.39
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 3.39
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 3.38
Defective structural RNA processing in relapsing-remitting multiple sclerosis 3.37
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 3.36
Hepatic transcriptome of pediatric hepatoblastoma. 3.36
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 3.26
Modeling Human Cancer-induced Cachexia (Human) 3.25
yylncT acts as a gatekeeper of the mesodermal transcriptional program by local modulation of DNMT3B [human_2] 3.23
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 3.16
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 3.16
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 3.14
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 3.07
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 2.96
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 2.94
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 2.94
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 2.9
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 2.86
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 2.85
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 2.83
Regulatory network controlling tumor-promoting inflammation in human cancers 2.77
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 2.77
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 2.7
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 2.63
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 2.59
Dermal endothelial cells of type 2 diabetic patients 2.52
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 2.52
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 2.51
Gene expression patterns define the hepatocyte-like cells derived by different strategies [RNA-seq] 2.36
Gene expression patterns define the hepatocyte-like cells derived by different strategies 2.36
Identifying deer antler proliferation and mineralization genes using comparative RNA-seq 2.33
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 2.31
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 2.25
Expression charcaterization of an internal protocol developed to differentiate RPE cells 2.24
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 2.22
WNT signaling memory is required for ACTIVIN to function as a morphogen 2.21
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 2.15
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 2.15
RNA seq analysis of human Fetal and adult derived Enterospheres 2.0
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 1.99
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 1.99
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 1.97
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 1.97
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 1.97
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 1.96
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 1.94
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 1.75
RNA-Seq of the corpus callosum from 12 individuals 1.71
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 1.69
iPSCs Reveal Protective Modifiers of the BMPR2 mutation in Pulmonary Arterial Hypertension 1.68
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 1.68
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 1.64
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq 1.62
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 1.6
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 1.59
Safety profiling of genetically engineered Pim-1 kinase overexpression for oncogenicity risk in human c-kit+ cardiac interstitial cells 1.58
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 1.57
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 1.38
MRTF activates TEAD-YAP target gene expression 1.38
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 1.38
Repurposing of promoters and enhancers during mammalian evolution 1.36
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 1.35
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 1.34
Gene expression profile of CRC-derived HILEC 1.24
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 1.16
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 1.15
Transcriptional landscape changes during human embryonic stem cell derivation 0.95
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 0.95
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells [RNA-seq] 0.92
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells 0.92
Expression analysis of the TAF1 syndrome 0.82
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 0.8
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 0.78
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 0.73
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 0.68
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 0.67
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.63
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 0.6
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 0.57
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 0.56
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 0.52
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 0.5
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 0.5
RNAseq of Breast cancer PDX samples 0.45
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 0.44
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 0.44
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.37
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 0.33
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 0.33
Expression profiles of the four human major ectodermal lineages 0.33
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.28
Epigenomic conservation of transposable element silencing 0.28
Epigenomic conservation of transposable element silencing [RNA-seq] 0.28
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.28
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 0.26
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 0.24
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 0.22
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 0.22
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 0.19
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.18
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 0.14
Whole transcriptome sequencing of the human thyroid primary cells with knock-down of the NRG1 gene 0.14
RNA-Seq of Breast and Ovarian Cancer Cell Lines 0.12
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 0.1
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 0.06
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 0.05
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation